Beacon Therapeutics (USA) Inc formerly Applied Genetic Technologies Corp, is into the development of eye disease cures. Beacon develops treatments for patients who have diseases caused by broken genes. It offers products such as X-linked retinitis pigmentosa, achromatopsia, bionic sight, age-related macular degeneration, non-syndromic hearing loss and deafness, frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). AGTC offers clinical trials. It focuses in the genetic therapies that can restore visual function in patients. The company also offers ophthalmology development programs and proof-of-concept data in multiple indications. Beacon is headquartered in Alachua, Florida, the US.
Products and Services
Products | Services |
---|---|
X-Linked Retinitis Pigmentosa | Clinical Trials |
Achromatopsia | |
Non-Syndromic Hearing Loss and Deafness | |
XYZ | |
XYZ | |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Asset Disposal | In April, the company sold the CMC team and site in Alachua, Florida, the US to Ascend Advanced Therapies. |
2022 | Others | In November, the company received a takeover offer from Syncona Limited. |
2021 | Contracts/Agreements | In April, the company entered into a licensing agreement with SparingVision SAS to provide its proprietary cone specific promoter technology. |
Competitor Comparison
Key Parameters | Beacon Therapeutics (USA) Inc | International Stem Cell Corp | MediciNova Inc | Cytodyn Inc | Kubota Vision Inc |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Alachua | Carlsbad | La Jolla | Vancouver | Seattle |
State/Province | Florida | California | California | Washington | Washington |
No. of Employees | 102 | 29 | 13 | 12 | - |
Entity Type | Private | Public | Public | Public | Private |
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Susan B. Washer | Chief Executive Officer; President; Director | Executive Board | - | - |
Jonathan I. Lieber | Chief Financial Officer | Senior Management | - | - |
Jerry Reynolds | Chief Accounting Officer; Treasurer | Senior Management | 2020 | - |
NadiaWaheed | Chief Medical Officer | Senior Management | - | - |
Abraham Scaria | Chief Scientific Officer | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer